Private Capital Group, LLC Akari Therapeutics PLC Transaction History

Private Capital Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$1.69 - $2.85 $108 - $182	-64 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$1.81 - $3.88 $61 - $131	-34 Reduced 34.69%	64 $0
Q3 2020 Nov 12, 2020	SELL	$1.58 - $2.37 $3,597 - $5,396	-2,277 Reduced 95.87%	98 $0
Q2 2020 Aug 13, 2020	SELL	$1.16 - $2.61 $331 - $746	-286 Reduced 10.75%	2,375 $5,000
Q1 2020 May 07, 2020	BUY	$1.06 - $2.16 $1,331 - $2,712	1,256 Added 89.4%	2,661 $4,000
Q4 2019 Feb 14, 2020	BUY	$1.69 - $2.16 $2,374 - $3,034	1,405 New	1,405 $2,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $59.3M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.